---
figid: PMC7098175__fphar-11-00193-g003
figtitle: Antitumor mechanism of CT
organisms:
- NA
pmcid: PMC7098175
filename: fphar-11-00193-g003.jpg
figlink: pmc/articles/PMC7098175/figure/F3/
number: F3
caption: The antitumor mechanism of CT. Cryptotanshinone inhibits the proliferation
  of cancer cells and induces autophagy and apoptosis by inhibiting IGF-1, IL-6, and
  glycolysis and mediating the cell cycle and mitochondrial pathway and inhibits angiogenesis
  by inhibiting the LPS/Wnt signaling pathway. The arrow represents the promotion
  effect, and the T area represents the inhibition effect.
papertitle: The Anticancer Properties of Tanshinones and the Pharmacological Effects
  of Their Active Ingredients.
reftext: Li Fu, et al. Front Pharmacol. 2020;11:193.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9596658
figid_alias: PMC7098175__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7098175__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7098175__fphar-11-00193-g003.html
  '@type': Dataset
  description: The antitumor mechanism of CT. Cryptotanshinone inhibits the proliferation
    of cancer cells and induces autophagy and apoptosis by inhibiting IGF-1, IL-6,
    and glycolysis and mediating the cell cycle and mitochondrial pathway and inhibits
    angiogenesis by inhibiting the LPS/Wnt signaling pathway. The arrow represents
    the promotion effect, and the T area represents the inhibition effect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - IL6
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - IGF1
  - TP53
  - TP63
  - TP73
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - BAD
  - BAK1
  - JAK2
  - CTNNB1
  - BCL2
  - CDK1
  - POLD1
  - TOP2A
  - JAK1
  - JAK3
  - TYK2
  - STAT3
  - PTPN11
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - TSC2
  - MAPK8
  - MAPK9
  - MAPK10
  - WARS1
  - HIF1A
  - LDHA
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - AKT1
  - AKT2
  - AKT3
  - TNF
  - RHEB
  - RHEBP1
  - SIRT3
  - MTOR
  - RPTOR
  - ELAVL1
  - CCND1
  - RPS6KB1
  - EIF4EBP1
  - BCL2L1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - Glucose
  - LPS
---
